Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0J3OZ
|
||||
Former ID |
DNC006245
|
||||
Drug Name |
2-(pyrimidin-4-ylamino)thiazole-5-carbonitrile
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [527935] | ||
Structure |
Download2D MOL |
||||
Formula |
C8H5N5S
|
||||
Canonical SMILES |
C1=CN=CN=C1NC2=NC=C(S2)C#N
|
||||
InChI |
1S/C8H5N5S/c9-3-6-4-11-8(14-6)13-7-1-2-10-5-12-7/h1-2,4-5H,(H,10,11,12,13)
|
||||
InChIKey |
SMNGUXOKYVUIRA-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Vascular endothelial growth factor receptor 2 | Target Info | Inhibitor | [527935] | |
NetPath Pathway | IL2 Signaling Pathway | ||||
PANTHER Pathway | Angiogenesis | ||||
VEGF signaling pathway | |||||
Pathway Interaction Database | HIF-2-alpha transcription factor network | ||||
Beta3 integrin cell surface interactions | |||||
Signaling events mediated by TCPTP | |||||
SHP2 signaling | |||||
S1P1 pathway | |||||
VEGF and VEGFR signaling network | |||||
Integrins in angiogenesis | |||||
Signaling events mediated by VEGFR1 and VEGFR2 | |||||
Notch-mediated HES/HEY network | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.